.png)
.png)
Latest news from BIA
BIA responds to new government investment to attract world's best in science and innovation
The BIA has to responded to the announcement from government of the inaugural UKRI Future Leaders Fellowship Scheme will receive £900 million over the next 11 years. BIA CEO Steve Bates said: “Today’s announcement will help to boost innovation in the UK and I am delighted to see that businesses will be able to use this scheme. It is vital that the UK government continues to support young entrepreneurs and business leaders to secure the innovation pipeline in the UK for the future.”
BIA welcomes new £2.5bn fund for innovative UK businesses
The BIA welcomes the creation of British Patient Capital, a £2.5 billion fund launched today by the British Business Bank. The fund will provide long-term funding to support the growth of innovative UK bioscience companies and other sectors.
New Industrial Biotechnology Strategy launched to secure UK leadership in clean growth
Today the Industrial Biotechnology Leadership Forum (IBLF) launches the new ‘National Industrial Biotechnology Strategy to 2030’, promoted in partnership with the UK BioIndustry Association (BIA). The Strategy has been developed by the IBLF and two collaborative networks in industrial biotech, CBMNet and BIOCATNET.
BIA comment on Government response to the Health Committee’s report on Brexit and medicines, medical devices and substances of human origin
The BIA has commented on the Government’s response to the Health Committee’s report on Brexit and medicines, medical devices and substances of human origin.
David Venables wins the Disruptor category of EY Entrepreneur Of The Year 2018, Scotland
Synpromics, the leader in gene control, is delighted to announce that David Venables, CEO of the Company, has won the ‘Disruptor’ category of Scotland’s EY Entrepreneur Of The Year 2018.
US$1.3 MILLION* GRANT AWARDED TO ARECOR & MANCHESTER INSTITUTE OF BIOTECHNOLOGY FROM INNOVATE UK
“Grant to significantly advance Arecor’s proprietary co-formulation platform in the development of diabetes therapies that meet critical patient unmet needs”
ARECOR ANNOUNCES SUPERFAST INSULIN DATA PRESENTATIONS
ARECOR ANNOUNCES SUPERFAST INSULIN DATA PRESENTATIONS AT THE AMERICAN DIABETES ASSOCIATION 78TH SCIENTIFIC SESSIONS
Adaptix Imaging is winner of The Oxford Science Park Innovation Award 2018
Oxford, UK, June 20 2018 - Adaptix Imaging’s progress in developing a new generation of low radiation dose affordable medical scanners has been recognised at the 2018 Oxfordshire Business Awards, where it has won The Oxford Science Park Innovation Award.
Video of the week: Fighting TB in Madagascar, with real time portable DNA sequencing
The fight against multi drug-resistant tuberculosis in Madagascar is being aided by Oxford Nanopore's powerful technology which allows DNA sequencing in real time, using a device which weighs less than 100g, capable of producing 10-20Gb of DNA sequence data.
CEO Update: Monday 18 June
Last week we saw some great news for our sector. The £2.5 billion British Patient Capital fund, launched by the British Business Bank, will provide long-term funding to support the growth of innovative UK bioscience companies and other sectors and will help to build the next generation of UK life science companies to scale to global leadership.
Video of the week: Opportunities for UK Life Sciences companies in China
Find out how the business and regulatory environment is changing, and hear from Department for International Trade experts based in China, from UK Life Sciences companies who have invested there and from organisations in China who can help with advice and incubation services.
CEO Update: Monday 11 June
Last week, the BIA was out in Boston for BIO 2018. UK companies became Official World record holders, showcasing UK excellence, and partnering and engaging with the international biotech community.
Please find a selection of featured BIA publications below. To see our full publications library, click here.
Influencing and shaping our sector, BIA update: January - April 2018
This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences industry, from January to April 2018.
Biotech Financing Update: December 2017 to February 2018
The BIA/Informa Biotech Financing Update: December 2017-February 2018 released today shows that venture capital financing and follow on financing on the public markets are off to a solid start in 2018.
Pipeline Progressing: The UK's Global Bioscience Cluster in 2017
A new report released by the BioIndustry Association (BIA) and Informa Pharma Intelligence reveals that the UK has the strongest clinical and preclinical pipeline in Europe.
BIA Best practice guide for communicating R&D
Ensuring investors and the wider public are well informed and confident about bioscience is crucial to the success of individual companies and the sector as a whole. To support the sector to maintain high standards in communications about R&D progress, the BIA has produced a best practice guide for bioscience companies with a supporting library of resources.
